Skip to content

The expression of GJB3 in colorectal cancer and its clinical significance

The expression of GJB3 in colorectal cancer and its clinical significance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120521
Enrollment
Unknown
Registered
2026-03-16
Start date
2025-11-10
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon carcinoma in situ, rectal carcinoma in situ

Interventions

Adjacent tissue group:None
Cancer tissue group:None

Sponsors

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The first confirmed case of colorectal cancer; 2.The patient has a clear pathological diagnosis; 3.The medical records are complete; 4.The patient has not received any anti-tumor treatments such as surgery, chemotherapy, radiotherapy, or biological therapy; 5.Age >=18 years old;

Exclusion criteria

Exclusion criteria: 1.Patients with other malignant tumors; 2.Patients with autoimmune diseases; 3.Patients with mental disorders; 4.Patients who have received anti-tumor treatments such as surgery, chemotherapy, radiotherapy and biological therapy before the operation; 5.Patients who have not received ESD treatment; 6.Age <18 years old;

Design outcomes

Primary

MeasureTime frame
The expression of GJB3 in colorectal cancer tissues and adjacent tissues;

Secondary

MeasureTime frame
Baseline data of colorectal cancer patients: gender, age, pathological data;

Countries

China

Contacts

Public ContactGuo Qiang

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

gq20061282@163.com+86 472 2178741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026